Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Ask the record
Help
Methodology
Signal backtests
Terms
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Pricing Sign in

Nomura Phase4 Ventures GP LTD — GYRE THERAPEUTICS, INC. insider · InsiderLens

/ / Nomura Phase4 Ventures GP LTD

Nomura Phase4 Ventures GP LTD

Member of 13G Group at GYRE THERAPEUTICS, INC. · on record since May 8, 2006
Shareholder at Altus Pharmaceuticals Inc. · on record since Nov 15, 2006
10% owner at Altus Pharmaceuticals Inc. · on record since Nov 14, 2006
10% owner at ACADIA PHARMACEUTICALS INC · on record since Aug 26, 2005
Member of 13G Group (1) at ACADIA PHARMACEUTICALS INC · on record since Aug 26, 2005

Insider trading activity of Nomura Phase4 Ventures GP LTD

No transactions on record for Nomura Phase4 Ventures GP LTD.

Track record of Nomura Phase4 Ventures GP LTD

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Nomura Phase4 Ventures GP LTD

Co-insiders of Nomura Phase4 Ventures GP LTD

NOMURA INTERNATIONAL PLCACADIA PHARMACEUTICALS INC +2
Nomura Phase4 Ventures LPACADIA PHARMACEUTICALS INC +2
Nomura Phase4 Ventures LTDACADIA PHARMACEUTICALS INC +2
Richard John PAltus Pharmaceuticals Inc. +1
14159, L.P.ACADIA PHARMACEUTICALS INC
667, L.P.ACADIA PHARMACEUTICALS INC
Aasen Thomas HACADIA PHARMACEUTICALS INC
ALDRICH RICHARDAltus Pharmaceuticals Inc.
Attie KennethAltus Pharmaceuticals Inc.
Baity GlennACADIA PHARMACEUTICALS INC
Baker Bros. Advisors (GP) LLCACADIA PHARMACEUTICALS INC
BAKER BROS. ADVISORS LPACADIA PHARMACEUTICALS INC
Baker Brothers Life Sciences LPACADIA PHARMACEUTICALS INC
BAKER FELIXACADIA PHARMACEUTICALS INC
BAKER JULIANACADIA PHARMACEUTICALS INC
BARNES JEFFREY TACADIA PHARMACEUTICALS INC
BARRETT M JAMESGYRE THERAPEUTICS, INC.
BARRIS PETER JGYRE THERAPEUTICS, INC.
Bencherif MerouaneGYRE THERAPEUTICS, INC.
Bergmann Joshua BenjaminGYRE THERAPEUTICS, INC.
Berkle SheldonAltus Pharmaceuticals Inc.
Biggar Stephen RACADIA PHARMACEUTICALS INC
Binder Gordon MACADIA PHARMACEUTICALS INC
BIOTECHNOLOGY VALUE FUND II LPGYRE THERAPEUTICS, INC.
BIOTECHNOLOGY VALUE FUND L PGYRE THERAPEUTICS, INC.
BLANK BURKHARDAltus Pharmaceuticals Inc.

This page republishes public regulatory disclosures.

BLIXT CHARLES AGYRE THERAPEUTICS, INC.

BORER MICHAEL TACADIA PHARMACEUTICALS INC

Brann Mark RACADIA PHARMACEUTICALS INC

Brege LauraACADIA PHARMACEUTICALS INC

Breitling ThomasAltus Pharmaceuticals Inc.

Brennan Jeffrey PGYRE THERAPEUTICS, INC.

BROWN JULIA RGYRE THERAPEUTICS, INC.

BRUM LYNNE HAltus Pharmaceuticals Inc.

BURRILL STEVENGYRE THERAPEUTICS, INC.

Burstyn Don GAltus Pharmaceuticals Inc.

BVF INC/ILGYRE THERAPEUTICS, INC.

BVF INVESTMENTS LLCGYRE THERAPEUTICS, INC.

BVF PARTNERS L P/ILGYRE THERAPEUTICS, INC.

Caldwell William SGYRE THERAPEUTICS, INC.

Carmichael GordonGYRE THERAPEUTICS, INC.

CARTHY MARKACADIA PHARMACEUTICALS INC

Chen RuoyuGYRE THERAPEUTICS, INC.

Connors Timothy JAltus Pharmaceuticals Inc.

Daly James MACADIA PHARMACEUTICALS INC

Davis Robert EACADIA PHARMACEUTICALS INC

DAVIS STEPHENACADIA PHARMACEUTICALS INC

deBethizy J DonaldGYRE THERAPEUTICS, INC.

DESOUZA ERROL BGYRE THERAPEUTICS, INC.

Dunbar Geoffrey CGYRE THERAPEUTICS, INC.

Concerned by this data? Exercise your right to object →

No transactions on record. Reset filters